Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 268 entries
Sorted by: Best Match Show Resources per page
Association of Overactive Bladder With Hypertension and Blood Pressure Control: The Multi-Ethnic Study of Atherosclerosis (MESA).

American journal of hypertension

Akbar A, Liu K, Michos ED, Bancks MP, Brubaker L, Markossian T, Durazo-Arvizu R, Kramer H.
PMID: 33899909
Am J Hypertens. 2022 Jan 05;35(1):22-30. doi: 10.1093/ajh/hpaa186.

BACKGROUND: The sudden urge to urinate, also known as overactive bladder (OAB), may reflect higher sympathetic activity and associate with higher blood pressure (BP).METHODS: This cross-sectional analysis utilized data from sixth follow-up exam (2015-2016) of Multi-Ethnic Study of Atherosclerosis...

Cite
Akbar A, Liu K, Michos ED, et al. Association of Overactive Bladder With Hypertension and Blood Pressure Control: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Hypertens. 2022;35(1):22-30doi: 10.1093/ajh/hpaa186.
Akbar, A., Liu, K., Michos, E. D., Bancks, M. P., Brubaker, L., Markossian, T., Durazo-Arvizu, R., & Kramer, H. (2022). Association of Overactive Bladder With Hypertension and Blood Pressure Control: The Multi-Ethnic Study of Atherosclerosis (MESA). American journal of hypertension, 35(1), 22-30. https://doi.org/10.1093/ajh/hpaa186
Akbar, Aelia, et al. "Association of Overactive Bladder With Hypertension and Blood Pressure Control: The Multi-Ethnic Study of Atherosclerosis (MESA)." American journal of hypertension vol. 35,1 (2022): 22-30. doi: https://doi.org/10.1093/ajh/hpaa186
Akbar A, Liu K, Michos ED, Bancks MP, Brubaker L, Markossian T, Durazo-Arvizu R, Kramer H. Association of Overactive Bladder With Hypertension and Blood Pressure Control: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Hypertens. 2022 Jan 05;35(1):22-30. doi: 10.1093/ajh/hpaa186. PMID: 33899909.
Copy Download .nbib Format: NLM
African Ancestry vs. Creatine Kinase to Predict Hypertension Control: Time for a Change?.

American journal of hypertension

Brewster LM, Van Valkengoed I, van Montfrans GA.
PMID: 34272843
Am J Hypertens. 2021 Dec 01;34(12):1264-1268. doi: 10.1093/ajh/hpab114.

BACKGROUND: African ancestry patients are considered separately in hypertension guidelines because of more severe hypertension that is presumably harder to control. However, despite the perceived benefit in reducing health disparities, racial profiling in medicine is increasingly criticized for its...

Cite
Brewster LM, Van Valkengoed I, van Montfrans GA. African Ancestry vs. Creatine Kinase to Predict Hypertension Control: Time for a Change?. Am J Hypertens. 2021;34(12):1264-1268doi: 10.1093/ajh/hpab114.
Brewster, L. M., Van Valkengoed, I., & van Montfrans, G. A. (2021). African Ancestry vs. Creatine Kinase to Predict Hypertension Control: Time for a Change?. American journal of hypertension, 34(12), 1264-1268. https://doi.org/10.1093/ajh/hpab114
Brewster, Lizzy M, et al. "African Ancestry vs. Creatine Kinase to Predict Hypertension Control: Time for a Change?." American journal of hypertension vol. 34,12 (2021): 1264-1268. doi: https://doi.org/10.1093/ajh/hpab114
Brewster LM, Van Valkengoed I, van Montfrans GA. African Ancestry vs. Creatine Kinase to Predict Hypertension Control: Time for a Change?. Am J Hypertens. 2021 Dec 01;34(12):1264-1268. doi: 10.1093/ajh/hpab114. PMID: 34272843.
Copy Download .nbib Format: NLM
Morphologically Normal-Appearing Adrenal Glands as a Prevalent Source of Aldosterone Production in Primary Aldosteronism.

American journal of hypertension

Parksook WW, Yozamp N, Hundemer GL, Moussa M, Underhill J, Fudim T, Sacks B, Vaidya A.
PMID: 34883509
Am J Hypertens. 2021 Dec 09; doi: 10.1093/ajh/hpab189. Epub 2021 Dec 09.

BACKGROUND: Normal-appearing adrenal glands on cross-sectional imaging may still be the source of aldosterone production in primary aldosteronism (PA).METHODS: We evaluated the prevalence of aldosterone production among morphologically normal-appearing adrenal glands and the impact of this phenomenon on interpretations...

Cite
Parksook WW, Yozamp N, Hundemer GL, et al. Morphologically Normal-Appearing Adrenal Glands as a Prevalent Source of Aldosterone Production in Primary Aldosteronism. Am J Hypertens. 2021;doi: 10.1093/ajh/hpab189.
Parksook, W. W., Yozamp, N., Hundemer, G. L., Moussa, M., Underhill, J., Fudim, T., Sacks, B., & Vaidya, A. (2021). Morphologically Normal-Appearing Adrenal Glands as a Prevalent Source of Aldosterone Production in Primary Aldosteronism. American journal of hypertension, . https://doi.org/10.1093/ajh/hpab189
Parksook, Wasita W, et al. "Morphologically Normal-Appearing Adrenal Glands as a Prevalent Source of Aldosterone Production in Primary Aldosteronism." American journal of hypertension vol. (2021). doi: https://doi.org/10.1093/ajh/hpab189
Parksook WW, Yozamp N, Hundemer GL, Moussa M, Underhill J, Fudim T, Sacks B, Vaidya A. Morphologically Normal-Appearing Adrenal Glands as a Prevalent Source of Aldosterone Production in Primary Aldosteronism. Am J Hypertens. 2021 Dec 09; doi: 10.1093/ajh/hpab189. Epub 2021 Dec 09. PMID: 34883509.
Copy Download .nbib Format: NLM
Midlife Blood Pressure Variability and Risk of All-Cause Mortality and Cardiovascular Events During Extended Follow-up.

American journal of hypertension

de Havenon A, Delic A, Yaghi S, Wong KH, Majersik JJ, Stulberg E, Tirschwell D, Anadani M.
PMID: 34240111
Am J Hypertens. 2021 Dec 01;34(12):1269-1275. doi: 10.1093/ajh/hpab106.

BACKGROUND: Studies demonstrate an association between visit-to-visit blood pressure variability (BPV) and cardiovascular events and death. We aimed to determine the long-term cardiovascular and mortality effects of BPV in midlife in participants with and without cardiovascular risk factors.METHODS: This...

Cite
de Havenon A, Delic A, Yaghi S, et al. Midlife Blood Pressure Variability and Risk of All-Cause Mortality and Cardiovascular Events During Extended Follow-up. Am J Hypertens. 2021;34(12):1269-1275doi: 10.1093/ajh/hpab106.
de Havenon, A., Delic, A., Yaghi, S., Wong, K. H., Majersik, J. J., Stulberg, E., Tirschwell, D., & Anadani, M. (2021). Midlife Blood Pressure Variability and Risk of All-Cause Mortality and Cardiovascular Events During Extended Follow-up. American journal of hypertension, 34(12), 1269-1275. https://doi.org/10.1093/ajh/hpab106
de Havenon, Adam, et al. "Midlife Blood Pressure Variability and Risk of All-Cause Mortality and Cardiovascular Events During Extended Follow-up." American journal of hypertension vol. 34,12 (2021): 1269-1275. doi: https://doi.org/10.1093/ajh/hpab106
de Havenon A, Delic A, Yaghi S, Wong KH, Majersik JJ, Stulberg E, Tirschwell D, Anadani M. Midlife Blood Pressure Variability and Risk of All-Cause Mortality and Cardiovascular Events During Extended Follow-up. Am J Hypertens. 2021 Dec 01;34(12):1269-1275. doi: 10.1093/ajh/hpab106. PMID: 34240111; PMCID: PMC8643578.
Copy Download .nbib Format: NLM
Association of Cytochrome P450 2C9*3 and Angiotensin II Receptor 1 (1166A>C) Gene Polymorphisms With the Antihypertensive Effect of Irbesartan.

American journal of hypertension

Dong H, Wang FZ, Shi K, Zhang XS, Lv DM.
PMID: 33599747
Am J Hypertens. 2021 Feb 18;34(1):121. doi: 10.1093/ajh/hpaa134.

BACKGROUND: To analyze whether the cytochrome P450 enzyme 2C9*3 (CYP2C9*3) and angiotensin II receptor 1 (AGTR1) (1166A>C) gene polymorphisms are associated with the risk of essential hypertension (EH) and the antihypertensive effect of irbesartan.METHODS: A total of 2,057 EH...

Cite
Dong H, Wang FZ, Shi K, et al. Association of Cytochrome P450 2C9*3 and Angiotensin II Receptor 1 (1166A>C) Gene Polymorphisms With the Antihypertensive Effect of Irbesartan. Am J Hypertens. 2021;34(1):121doi: 10.1093/ajh/hpaa134.
Dong, H., Wang, F. Z., Shi, K., Zhang, X. S., & Lv, D. M. (2021). Association of Cytochrome P450 2C9*3 and Angiotensin II Receptor 1 (1166A>C) Gene Polymorphisms With the Antihypertensive Effect of Irbesartan. American journal of hypertension, 34(1), 121. https://doi.org/10.1093/ajh/hpaa134
Dong, Hui, et al. "Association of Cytochrome P450 2C9*3 and Angiotensin II Receptor 1 (1166A>C) Gene Polymorphisms With the Antihypertensive Effect of Irbesartan." American journal of hypertension vol. 34,1 (2021): 121. doi: https://doi.org/10.1093/ajh/hpaa134
Dong H, Wang FZ, Shi K, Zhang XS, Lv DM. Association of Cytochrome P450 2C9*3 and Angiotensin II Receptor 1 (1166A>C) Gene Polymorphisms With the Antihypertensive Effect of Irbesartan. Am J Hypertens. 2021 Feb 18;34(1):121. doi: 10.1093/ajh/hpaa134. PMID: 33599747.
Copy Download .nbib Format: NLM
MicroRNA-183 as a Novel Regulator Protects Against Cardiomyocytes Hypertrophy via Targeting TIAM1.

American journal of hypertension

Gong FH, Chen XL, Zhang Q, Xiao XQ, Yang YS, Song BJ, Chao SP, Cheng WL.
PMID: 32870256
Am J Hypertens. 2022 Jan 05;35(1):87-95. doi: 10.1093/ajh/hpaa144.

BACKGROUND: MicroRNAs serve as important regulators of the pathogenesis of cardiac hypertrophy. Among them, miR-183 is well documented as a novel tumor suppressor in previous studies, whereas it exhibits a downregulated expression in cardiac hypertrophy recently. The present study...

Cite
Gong FH, Chen XL, Zhang Q, et al. MicroRNA-183 as a Novel Regulator Protects Against Cardiomyocytes Hypertrophy via Targeting TIAM1. Am J Hypertens. 2022;35(1):87-95doi: 10.1093/ajh/hpaa144.
Gong, F. H., Chen, X. L., Zhang, Q., Xiao, X. Q., Yang, Y. S., Song, B. J., Chao, S. P., & Cheng, W. L. (2022). MicroRNA-183 as a Novel Regulator Protects Against Cardiomyocytes Hypertrophy via Targeting TIAM1. American journal of hypertension, 35(1), 87-95. https://doi.org/10.1093/ajh/hpaa144
Gong, Fu-Han, et al. "MicroRNA-183 as a Novel Regulator Protects Against Cardiomyocytes Hypertrophy via Targeting TIAM1." American journal of hypertension vol. 35,1 (2022): 87-95. doi: https://doi.org/10.1093/ajh/hpaa144
Gong FH, Chen XL, Zhang Q, Xiao XQ, Yang YS, Song BJ, Chao SP, Cheng WL. MicroRNA-183 as a Novel Regulator Protects Against Cardiomyocytes Hypertrophy via Targeting TIAM1. Am J Hypertens. 2022 Jan 05;35(1):87-95. doi: 10.1093/ajh/hpaa144. PMID: 32870256.
Copy Download .nbib Format: NLM
Adipokines and metabolic syndrome: pluripotent markers for a complex relationship?.

American journal of hypertension

Pereira LG, da Silva-Santos JE.
PMID: 34849548
Am J Hypertens. 2021 Nov 29; doi: 10.1093/ajh/hpab184. Epub 2021 Nov 29.

No abstract available.

Cite
Pereira LG, da Silva-Santos JE. Adipokines and metabolic syndrome: pluripotent markers for a complex relationship?. Am J Hypertens. 2021;doi: 10.1093/ajh/hpab184.
Pereira, L. G., & da Silva-Santos, J. E. (2021). Adipokines and metabolic syndrome: pluripotent markers for a complex relationship?. American journal of hypertension, . https://doi.org/10.1093/ajh/hpab184
Pereira, Leonardo Gomes, and da Silva-Santos, J Eduardo. "Adipokines and metabolic syndrome: pluripotent markers for a complex relationship?." American journal of hypertension vol. (2021). doi: https://doi.org/10.1093/ajh/hpab184
Pereira LG, da Silva-Santos JE. Adipokines and metabolic syndrome: pluripotent markers for a complex relationship?. Am J Hypertens. 2021 Nov 29; doi: 10.1093/ajh/hpab184. Epub 2021 Nov 29. PMID: 34849548.
Copy Download .nbib Format: NLM
Plasma ceramides and cardiovascular events in hypertensive patients at high cardiovascular risk.

American journal of hypertension

Yin W, Li F, Tan X, Wang H, Jiang W, Wang X, Li S, Zhang Y, Han Q, Wang Y, Du J.
PMID: 34232291
Am J Hypertens. 2021 Jul 07; doi: 10.1093/ajh/hpab105. Epub 2021 Jul 07.

BACKGROUND: Plasma ceramides (Cer) have been used to evaluate risk of cardiovascular events in patients with coronary heart disease. We investigated the performance of ceramides and ceramide score (CERT) in hypertensive patients at high cardiovascular risk.METHODS: Seven ceramides were...

Cite
Yin W, Li F, Tan X, et al. Plasma ceramides and cardiovascular events in hypertensive patients at high cardiovascular risk. Am J Hypertens. 2021;doi: 10.1093/ajh/hpab105.
Yin, W., Li, F., Tan, X., Wang, H., Jiang, W., Wang, X., Li, S., Zhang, Y., Han, Q., Wang, Y., & Du, J. (2021). Plasma ceramides and cardiovascular events in hypertensive patients at high cardiovascular risk. American journal of hypertension, . https://doi.org/10.1093/ajh/hpab105
Yin, Wenjie, et al. "Plasma ceramides and cardiovascular events in hypertensive patients at high cardiovascular risk." American journal of hypertension vol. (2021). doi: https://doi.org/10.1093/ajh/hpab105
Yin W, Li F, Tan X, Wang H, Jiang W, Wang X, Li S, Zhang Y, Han Q, Wang Y, Du J. Plasma ceramides and cardiovascular events in hypertensive patients at high cardiovascular risk. Am J Hypertens. 2021 Jul 07; doi: 10.1093/ajh/hpab105. Epub 2021 Jul 07. PMID: 34232291.
Copy Download .nbib Format: NLM
The Retail Outlet Health Kiosk Hypertension Trial (ROKHYT): Pilot Results.

American journal of hypertension

Shea S, Thompson JLP, Schwartz JE, Chen Y, de Ferrante M, Vanderbeek AM, Buchsbaum R, Vargas C, Siddiqui KM, Moran AE, Stockwell M.
PMID: 34382648
Am J Hypertens. 2022 Jan 05;35(1):103-110. doi: 10.1093/ajh/hpab129.

BACKGROUND: Blood pressure (BP) control was only 43.7% in the National Health and Nutrition Survey (NHANES) survey in 2017-2018. Scalable, nonclinic-based strategies to control BP are needed. We therefore conducted a pilot trial of a text-messaging intervention in a...

Cite
Shea S, Thompson JLP, Schwartz JE, et al. The Retail Outlet Health Kiosk Hypertension Trial (ROKHYT): Pilot Results. Am J Hypertens. 2022;35(1):103-110doi: 10.1093/ajh/hpab129.
Shea, S., Thompson, J. L. P., Schwartz, J. E., Chen, Y., de Ferrante, M., Vanderbeek, A. M., Buchsbaum, R., Vargas, C., Siddiqui, K. M., Moran, A. E., & Stockwell, M. (2022). The Retail Outlet Health Kiosk Hypertension Trial (ROKHYT): Pilot Results. American journal of hypertension, 35(1), 103-110. https://doi.org/10.1093/ajh/hpab129
Shea, Steven, et al. "The Retail Outlet Health Kiosk Hypertension Trial (ROKHYT): Pilot Results." American journal of hypertension vol. 35,1 (2022): 103-110. doi: https://doi.org/10.1093/ajh/hpab129
Shea S, Thompson JLP, Schwartz JE, Chen Y, de Ferrante M, Vanderbeek AM, Buchsbaum R, Vargas C, Siddiqui KM, Moran AE, Stockwell M. The Retail Outlet Health Kiosk Hypertension Trial (ROKHYT): Pilot Results. Am J Hypertens. 2022 Jan 05;35(1):103-110. doi: 10.1093/ajh/hpab129. PMID: 34382648; PMCID: PMC8730503.
Copy Download .nbib Format: NLM
Dietary Habits and Medications to Control Hypertension Among Women of Child-Bearing Age in the United States from 2001 to 2016.

American journal of hypertension

Kovell LC, Maxner B, Ayturk D, Moore Simas TA, Harrington CM, McManus DD, Gardiner P, Aurigemma GP, Juraschek SP.
PMID: 33693539
Am J Hypertens. 2021 Sep 22;34(9):919-928. doi: 10.1093/ajh/hpab041.

BACKGROUND: Hypertension (HTN) in pregnancy is a leading cause of maternal morbidity and mortality in the United States. Although the Dietary Approaches to Stop Hypertension (DASH) diet is recommended for all adults with HTN, rates of DASH adherence and...

Cite
Kovell LC, Maxner B, Ayturk D, et al. Dietary Habits and Medications to Control Hypertension Among Women of Child-Bearing Age in the United States from 2001 to 2016. Am J Hypertens. 2021;34(9):919-928doi: 10.1093/ajh/hpab041.
Kovell, L. C., Maxner, B., Ayturk, D., Moore Simas, T. A., Harrington, C. M., McManus, D. D., Gardiner, P., Aurigemma, G. P., & Juraschek, S. P. (2021). Dietary Habits and Medications to Control Hypertension Among Women of Child-Bearing Age in the United States from 2001 to 2016. American journal of hypertension, 34(9), 919-928. https://doi.org/10.1093/ajh/hpab041
Kovell, Lara C, et al. "Dietary Habits and Medications to Control Hypertension Among Women of Child-Bearing Age in the United States from 2001 to 2016." American journal of hypertension vol. 34,9 (2021): 919-928. doi: https://doi.org/10.1093/ajh/hpab041
Kovell LC, Maxner B, Ayturk D, Moore Simas TA, Harrington CM, McManus DD, Gardiner P, Aurigemma GP, Juraschek SP. Dietary Habits and Medications to Control Hypertension Among Women of Child-Bearing Age in the United States from 2001 to 2016. Am J Hypertens. 2021 Sep 22;34(9):919-928. doi: 10.1093/ajh/hpab041. PMID: 33693539; PMCID: PMC8457430.
Copy Download .nbib Format: NLM
Self-measured blood pressure monitoring among adults with self-reported hypertension in 20 US states and the District of Columbia, 2019.

American journal of hypertension

Fang J, Luncheon C, Wall HK, Wozniak G, Loustalot F.
PMID: 34097724
Am J Hypertens. 2021 Jun 07; doi: 10.1093/ajh/hpab091. Epub 2021 Jun 07.

BACKGROUND: Hypertension is a major risk factor for cardiovascular disease. Achieving hypertension control requires multiple supportive inventions, including self-measured blood pressure (SMBP). The objective of this study is to report the use of SMBP among US adults.METHODS: Behavioral Risk...

Cite
Fang J, Luncheon C, Wall HK, et al. Self-measured blood pressure monitoring among adults with self-reported hypertension in 20 US states and the District of Columbia, 2019. Am J Hypertens. 2021;doi: 10.1093/ajh/hpab091.
Fang, J., Luncheon, C., Wall, H. K., Wozniak, G., & Loustalot, F. (2021). Self-measured blood pressure monitoring among adults with self-reported hypertension in 20 US states and the District of Columbia, 2019. American journal of hypertension, . https://doi.org/10.1093/ajh/hpab091
Fang, Jing, et al. "Self-measured blood pressure monitoring among adults with self-reported hypertension in 20 US states and the District of Columbia, 2019." American journal of hypertension vol. (2021). doi: https://doi.org/10.1093/ajh/hpab091
Fang J, Luncheon C, Wall HK, Wozniak G, Loustalot F. Self-measured blood pressure monitoring among adults with self-reported hypertension in 20 US states and the District of Columbia, 2019. Am J Hypertens. 2021 Jun 07; doi: 10.1093/ajh/hpab091. Epub 2021 Jun 07. PMID: 34097724.
Copy Download .nbib Format: NLM
Associations Between Social Determinants and Hypertension, Stage 2 Hypertension, and Controlled Blood Pressure Among Men and Women in the United States.

American journal of hypertension

Commodore-Mensah Y, Turkson-Ocran RA, Foti K, Cooper LA, Himmelfarb CD.
PMID: 33428705
Am J Hypertens. 2021 Aug 09;34(7):707-717. doi: 10.1093/ajh/hpab011.

BACKGROUND: Social determinants influence the development and control of hypertension.METHODS: National Health and Nutrition Examination Survey (2011-2018) data for adults aged ≥18 included education, income, employment, race/ethnicity, healthcare access, marital status, and nativity status. Outcomes were hypertension (blood pressure...

Cite
Commodore-Mensah Y, Turkson-Ocran RA, Foti K, et al. Associations Between Social Determinants and Hypertension, Stage 2 Hypertension, and Controlled Blood Pressure Among Men and Women in the United States. Am J Hypertens. 2021;34(7):707-717doi: 10.1093/ajh/hpab011.
Commodore-Mensah, Y., Turkson-Ocran, R. A., Foti, K., Cooper, L. A., & Himmelfarb, C. D. (2021). Associations Between Social Determinants and Hypertension, Stage 2 Hypertension, and Controlled Blood Pressure Among Men and Women in the United States. American journal of hypertension, 34(7), 707-717. https://doi.org/10.1093/ajh/hpab011
Commodore-Mensah, Yvonne, et al. "Associations Between Social Determinants and Hypertension, Stage 2 Hypertension, and Controlled Blood Pressure Among Men and Women in the United States." American journal of hypertension vol. 34,7 (2021): 707-717. doi: https://doi.org/10.1093/ajh/hpab011
Commodore-Mensah Y, Turkson-Ocran RA, Foti K, Cooper LA, Himmelfarb CD. Associations Between Social Determinants and Hypertension, Stage 2 Hypertension, and Controlled Blood Pressure Among Men and Women in the United States. Am J Hypertens. 2021 Aug 09;34(7):707-717. doi: 10.1093/ajh/hpab011. PMID: 33428705; PMCID: PMC8351505.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 268 entries